Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.17%83.550.6%$351.99m
ISRGIntuitive Surgical, Inc.
-0.16%982.707.5%$335.86m
TMOThermo Fisher Scientific Inc.
0.83%174.011.0%$277.63m
BDXBecton, Dickinson and Company
0.73%199.141.3%$248.16m
ABTAbbott Laboratories
0.31%48.890.8%$240.95m
ZBHZimmer Biomet Holdings, Inc.
1.21%112.731.7%$185.21m
ALGNAlign Technology, Inc.
-0.37%167.986.2%$180.05m
BCRC. R. Bard, Inc.
0.39%319.441.6%$156.99m
SYKStryker Corporation
0.58%145.121.3%$153.90m
EWEdwards Lifesciences Corporation
0.97%114.211.2%$150.46m
BAXBaxter International Inc.
0.38%61.101.7%$146.15m
HOLXHologic, Inc.
0.56%37.631.6%$145.44m
BSXBoston Scientific Corporation
-0.02%26.891.1%$144.20m
XRAYDENTSPLY International Inc.
-0.11%52.793.0%$108.11m
WATWaters Corporation
0.25%180.143.3%$99.96m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.